Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Broker tips: Chemring, Standard Chartered

(Sharecast News) - Analysts at Berenberg raised their target price on technology products and services group Chemring from 360.0p to 420.0p on Wednesday, stating the firm's "strong" first-half performance had highlighted underlying momentum. Berenberg said Chemring's interim 2022 results demonstrated "continued strong operating momentum", with all key metrics meaningfully ahead of consensus.

The German bank stated Chemring's Roke unit continued to perform "very well", and said the planned investment into the business provided "a strong platform" for the momentum to be sustained in the coming years.

"While this higher investment, combined with inflationary pressure and US order delays, is expected to temper profitability in H2, we think the longer-term outlook remains bright," said the analysts.

Berenberg also noted that Chemring's higher-margin Sensors & Information division was also "well positioned" to win order opportunities linked to rising defence budgets, and thinks this will be "a source of upside" to outer-year estimates.

"Against this supportive backdrop, we reiterate our 'buy' rating and increase our price target to 420.0p, reflecting our raised outer-year estimates and higher peer multiples," concluded Berenberg.

Analysts at Jefferies reiterated their 'buy' recommendation for shares of Standard Chartered on Wednesday, highlighting the potential now for the lender to re-load its buy-back programme for the second quarter.

Jefferies pointed out that StanChart had finished the first quarter with a Common Equity Tier 1 capital cushion of 13.9% after removing $6.5bn of risk-weighted assets linked to corporate business with lower returns.

Although the analysts noted they were looking for further confirmation on those RWA savings at the lender's webinar, they said the savings confirmed expectations for a further $500.0m of buybacks to be announced alongside StanChart's second-quarter results. Through 2024, Jefferies now anticipates a cumulative capital return of $5.4bn.

The analysts also bumped up their revenue estimates for 2022-24 by 3.0% on average after embedding a cumulative 150 basis points of Fed interest rate hikes for the period, on top of the prior 75bp foreseen.

Jefferies, which has a 991.0p target price on the stock, also raised estimates for StanChart's net interest income over 2022-24 by 11%, leaving them 2.0% ahead of the analyst consensus.

Reporting by Iain Gilbert and Alexander Bueso at Sharecast.com

Share this article

Related Sharecast Articles

Broker tips: Volution, Videndum
(Sharecast News) - Jefferies reiterated its 'buy' rating and 510.0p target price on Volution on Wednesday as it said the company's ability to drive margins higher, through both revenue mix and efficiency, is more than offsetting the challenging market backdrop to deliver ongoing earning upgrades.
Broker tips: Marlowe, Fevertree
(Sharecast News) - Analysts at Berenberg slightly lowered their target price on software and services firm Marlowe from 720.0p to 710.0p on Tuesday but said the group's divestment of certain Governance, Risk and Compliance software and service assets had left it with a "much cleaner and simpler-to-understand equity story".
Broker tips: JD Sports, NatWest
(Sharecast News) - Barclays downgraded JD Sports on Monday to 'equalweight' from 'overweight' and cut its price target for the stock to 140.0p from 165.0p after the retailer announced the acquisition of US rival Hibbett last week for $1.1bn.
Broker tips: NatWest, Pensionbee, Greggs
(Sharecast News) - Shore Capital reiterated its 'buy' rating on bank NatWest after a forecast-beating first quarter but said it sees the least amount of upside potential in the stock compared with the wider banking sector.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.